These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 21725997

  • 1. Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans.
    Nair SS, Bommana A, Pakala SB, Ohshiro K, Lyon AJ, Suttiprapa S, Periago MV, Laha T, Hotez PJ, Bethony JM, Sripa B, Brindley PJ, Kumar R.
    Hepatology; 2011 Oct; 54(4):1388-97. PubMed ID: 21725997
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma.
    Akai PS, Pungpak S, Chaicumpa W, Viroj K, Bunnag D, Befus AD.
    Trans R Soc Trop Med Hyg; 1994 Oct; 88(4):471-4. PubMed ID: 7570848
    [Abstract] [Full Text] [Related]

  • 5. Opisthorchis viverrini: Gene expression profiling of carcinogenic adult liver fluke worms using 5' SAGE.
    Chutiwitoonchai N, Shen Y, Zheng H, Xiong H, Zhao G, Imtawil K, Intapan PM, Wongkham S, Wongkham C.
    Exp Parasitol; 2008 Dec; 120(4):306-13. PubMed ID: 18786530
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infection with the carcinogenic human liver fluke, Opisthorchis viverrini.
    Smout MJ, Sripa B, Laha T, Mulvenna J, Gasser RB, Young ND, Bethony JM, Brindley PJ, Loukas A.
    Mol Biosyst; 2011 May; 7(5):1367-75. PubMed ID: 21311794
    [Abstract] [Full Text] [Related]

  • 10. Cytokine profiles in Opisthorchis viverrini stimulated peripheral blood mononuclear cells from cholangiocarcinoma patients.
    Surapaitoon A, Suttiprapa S, Khuntikeo N, Pairojkul C, Sripa B.
    Parasitol Int; 2017 Feb; 66(1):889-892. PubMed ID: 27769807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with Opisthorchis viverrini.
    Chaiyadet S, Tangkawattana S, Smout MJ, Ittiprasert W, Mann VH, Deenonpoe R, Arunsan P, Loukas A, Brindley PJ, Laha T.
    PLoS Pathog; 2022 Sep; 18(9):e1010839. PubMed ID: 36137145
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma.
    Botelho MC, Alves H, Richter J.
    Parasitol Res; 2016 Jul; 115(7):2913-4. PubMed ID: 27130317
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distinct antibody response in susceptible and non-susceptible hosts of the carcinogenic liver fluke Opisthorchis viverrini infection.
    Watakulsin K, Surapaitoon A, Ulag LH, Kaing S, Suyapoh W, Saichua P, Salao K, Tangkawatana S, Suttiprapa S.
    Parasitology; 2023 Jul; 150(8):653-660. PubMed ID: 37288733
    [Abstract] [Full Text] [Related]

  • 19. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis.
    Techasen A, Loilome W, Namwat N, Duenngai K, Cha'on U, Thanan R, Sithithaworn P, Miwa M, Yongvanit P.
    Parasitol Int; 2012 Mar; 61(1):140-4. PubMed ID: 21763456
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.